A drug used during liver surgery may cut the risk of major complications — a study puts it to the test

NCT ID NCT07719933

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This study looks at whether giving a drug called terlipressin continuously during keyhole (laparoscopic) liver surgery can lower the chance of severe complications afterward. Terlipressin helps keep blood pressure stable, which may protect organs during surgery. Researchers will follow about 160 adults having liver tumor surgery and compare those who received the drug with those who did not.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
terlipressin, a drug that helps maintain blood pressure during surgery
What this could lead to
If it works, this could point toward a simple way to lower the risk of severe complications after liver surgery.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by other factors. The drug may also have side effects like reduced blood flow to organs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver and intrahepatic bile duct neoplasm Liver Neoplasms Pleural Effusion Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, 510080, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.